Paper351980
The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism.
Kakkar VV. World J Surg, 1978. Cited by 37 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism. Papers, record 351980. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/351980
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heparin | Major topic |
| Pulmonary Embolism | Major topic |
| Thrombophlebitis | Major topic |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Postoperative Complications | |
| Pregnancy | |
| Pregnancy Complications, Cardiovascular |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,817,700 | Heparin action. | Circulation | 1974 | https://conductscience.org/library/papers/4817700 | PubMed |
| 2 | 4,372,746 | Enhancement of plasminogen activator by vasopressin and adrenaline: a role of cyclic AMP? | Thromb Res | 1974 | https://conductscience.org/library/papers/4372746 | PubMed |
| 3 | 4,598,979 | Proceedings: Low dose subcutaneous heparin--optimal dose regimen. | Br J Surg | 1974 | https://conductscience.org/library/papers/4598979 | PubMed |
| 4 | 989,965 | Four heparin preparations: anti-Xa potentiating effect of heparin after subcutaneous injection. | Thromb Haemost | 1976 | https://conductscience.org/library/papers/989965 | PubMed |
| 5 | 4,740,341 | Thromboembolism after total hip reconstruction. Failure of low doses of heparin in prevention. | JAMA | 1973 | https://conductscience.org/library/papers/4740341 | PubMed |
| 6 | 1,036,806 | Low-dose heparin and deep-vein thrombosis after total hip replacement. | Thromb Haemost | 1976 | https://conductscience.org/library/papers/1036806 | PubMed |
| 7 | 790,636 | Plasma heparin levels after administration of calcium and sodium salts of heparin. | Thromb Res | 1976 | https://conductscience.org/library/papers/790636 | PubMed |
| 8 | 5,723,724 | Streptokinase therapy in acute major pulmonary embolism: effectiveness and problems. | Br Med J | 1968 | https://conductscience.org/library/papers/5723724 | PubMed |
| 9 | 4,138,248 | Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement. | Lancet | 1974 | https://conductscience.org/library/papers/4138248 | PubMed |
| 11 | 5,913,480 | Results in the prophylaxis of postoperative thromboembolism. | Surg Gynecol Obstet | 1966 | https://conductscience.org/library/papers/5913480 | PubMed |
| 12 | 4,843,085 | [Prevention of venous thrombosis. Success of high doses of heparin during total hip replacement for osteoarthritis]. | Nouv Presse Med | 1974 | https://conductscience.org/library/papers/4843085 | PubMed |
| 13 | 4,126,560 | A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. | Lancet | 1973 | https://conductscience.org/library/papers/4126560 | PubMed |
| 14 | 5,637,480 | Highly purified antithrombin 3 with heparin cofactor activity prepared by disc electrophoresis. | Scand J Clin Lab Invest | 1968 | https://conductscience.org/library/papers/5637480 | PubMed |
| 15 | 5,536,580 | Urokinase pulmonary embolism trial. Phase 1 results: a cooperative study. | JAMA | 1970 | https://conductscience.org/library/papers/5536580 | PubMed |
| 16 | 14,176,888 | THE CLINICAL USAGE OF HEPARIN. | Am J Cardiol | 1964 | https://conductscience.org/library/papers/14176888 | PubMed |
| 17 | 4,135,556 | Heparin versus dextran in the prevention of deep-vein thrombosis. A multi-unit coctrolled trial. | Lancet | 1974 | https://conductscience.org/library/papers/4135556 | PubMed |
| 18 | 4,107,902 | Prevention of postoperative deep-vein thrombosis with perioperative subcutaneous heparin. | Lancet | 1971 | https://conductscience.org/library/papers/4107902 | PubMed |
| 19 | 58,199 | Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement. | Lancet | 1976 | https://conductscience.org/library/papers/58199 | PubMed |
| 20 | 4,164,368 | The iliofemoral venous segment as a source of pulmonary emboli. | Lancet | 1967 | https://conductscience.org/library/papers/4164368 | PubMed |
| 21 | 4,744,294 | 125I fibrinogen and the prevention of venous thrombosis. | Arch Surg | 1973 | https://conductscience.org/library/papers/4744294 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,353,128 | Incidences of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low-dose heparin: an international multicentre study. | Br Med J | 1980 | https://conductscience.org/library/papers/7353128 | PubMed |
| 3,134,089 | Effect of low dose heparin on blood loss at caesarean section. | Br Med J (Clin Res Ed) | 1988 | https://conductscience.org/library/papers/3134089 | PubMed |
| 3,098,941 | Venous thromboembolism: epidemiology, diagnosis, prevention. | J Gen Intern Med | 1986 | https://conductscience.org/library/papers/3098941 | PubMed |
| 507,970 | Thrombotic complications of heparin therapy: including six cases of heparin--induced skin necrosis. | Ann Surg | 1979 | https://conductscience.org/library/papers/507970 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/351980
GET https://conductscience.org/api/papers/v1/351980/references?page=2